KR19990083234A - 치환된 삼환식 화합물 - Google Patents

치환된 삼환식 화합물 Download PDF

Info

Publication number
KR19990083234A
KR19990083234A KR1019990013439A KR19990013439A KR19990083234A KR 19990083234 A KR19990083234 A KR 19990083234A KR 1019990013439 A KR1019990013439 A KR 1019990013439A KR 19990013439 A KR19990013439 A KR 19990013439A KR 19990083234 A KR19990083234 A KR 19990083234A
Authority
KR
South Korea
Prior art keywords
alkyl
phenyl
arthritis
formula
nitrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019990013439A
Other languages
English (en)
Korean (ko)
Inventor
니콜라스 제임스 바크
졸리 앤 배스티안
더글라스 웨이드 베이트
마이클 딘 킨닉
마이클 존 마티넬리
에드워드 데이비드 미헬리치
존 마이클 주니어 모린
다니엘 존 샐
제이슨 스콧 소여
에드워드 씨.알. 스미쓰
툴리오 수아레쯔
큐핑 왕
토마스 마이클 윌슨
Original Assignee
피터 지. 스트링거
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 피터 지. 스트링거, 일라이 릴리 앤드 캄파니 filed Critical 피터 지. 스트링거
Publication of KR19990083234A publication Critical patent/KR19990083234A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
KR1019990013439A 1998-04-17 1999-04-16 치환된 삼환식 화합물 Withdrawn KR19990083234A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6216598A 1998-04-17 1998-04-17
US9/062,165 1998-04-17

Publications (1)

Publication Number Publication Date
KR19990083234A true KR19990083234A (ko) 1999-11-25

Family

ID=22040624

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019990013439A Withdrawn KR19990083234A (ko) 1998-04-17 1999-04-16 치환된 삼환식 화합물

Country Status (27)

Country Link
EP (2) EP0950661B1 (cg-RX-API-DMAC10.html)
JP (1) JP4435325B2 (cg-RX-API-DMAC10.html)
KR (1) KR19990083234A (cg-RX-API-DMAC10.html)
CN (1) CN1235968A (cg-RX-API-DMAC10.html)
AR (1) AR018185A1 (cg-RX-API-DMAC10.html)
AT (2) ATE254128T1 (cg-RX-API-DMAC10.html)
AU (1) AU757454B2 (cg-RX-API-DMAC10.html)
BR (1) BR9901275A (cg-RX-API-DMAC10.html)
CA (1) CA2269256A1 (cg-RX-API-DMAC10.html)
CO (1) CO5080728A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ137199A3 (cg-RX-API-DMAC10.html)
DE (2) DE69912670T2 (cg-RX-API-DMAC10.html)
EA (1) EA003129B1 (cg-RX-API-DMAC10.html)
ES (2) ES2210979T3 (cg-RX-API-DMAC10.html)
HU (1) HUP9901219A1 (cg-RX-API-DMAC10.html)
ID (1) ID23219A (cg-RX-API-DMAC10.html)
IL (1) IL129484A0 (cg-RX-API-DMAC10.html)
NO (1) NO991823L (cg-RX-API-DMAC10.html)
NZ (1) NZ335252A (cg-RX-API-DMAC10.html)
PE (1) PE20000472A1 (cg-RX-API-DMAC10.html)
PL (1) PL332564A1 (cg-RX-API-DMAC10.html)
SG (1) SG106035A1 (cg-RX-API-DMAC10.html)
SV (1) SV1999000052A (cg-RX-API-DMAC10.html)
TR (1) TR199900842A2 (cg-RX-API-DMAC10.html)
TW (1) TW555760B (cg-RX-API-DMAC10.html)
YU (1) YU19099A (cg-RX-API-DMAC10.html)
ZA (1) ZA992773B (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610728B2 (en) * 1997-08-28 2003-08-26 Eli Lilly And Company Method for treatment of non-rheumatoid arthritis
AU2001244635A1 (en) * 2000-03-30 2001-10-15 Yamanouchi Pharmaceutical Co..Ltd. Hydrazide derivatives
CN1450893A (zh) * 2000-07-14 2003-10-22 伊莱利利公司 治疗脓毒症的方法
ES2264708T3 (es) * 2000-12-18 2007-01-16 Eli Lilly And Company Derivados tetraciclicos como inhibidores de la spla2.
DE60218155D1 (de) 2001-03-28 2007-03-29 Lilly Co Eli Substituierte carbazole als inhibitoren von spla2
JP2005527466A (ja) 2001-08-09 2005-09-15 イーライ・リリー・アンド・カンパニー sPLA2インヒビターとしてのシクロヘプトBインドール誘導体
JP2005527464A (ja) * 2001-08-09 2005-09-15 イーライ・リリー・アンド・カンパニー sPLA2インヒビターとしてのシクロヘプタBインドール誘導体
US6992100B2 (en) 2001-12-06 2006-01-31 Eli Lilly And Company sPLA2 inhibitors
BRPI0517955A (pt) 2004-11-01 2008-10-21 Wyeth Corp indolizinas substituìdas e derivados como agentes de snc
CA2727055C (en) 2008-01-11 2016-12-20 Albany Molecular Research, Inc. (1-azinone) -substituted pyridoindoles as mch antagonists
WO2011003021A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2012088124A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
WO2012140612A1 (en) * 2011-04-14 2012-10-18 Actelion Pharmaceuticals Ltd 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
SG11201405328SA (en) 2012-03-16 2014-11-27 Vitae Pharmaceuticals Inc Liver x receptor modulators
ES2607113T3 (es) 2012-03-16 2017-03-29 Vitae Pharmaceuticals, Inc. Moduladores de los receptores X del hígado

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3979391A (en) * 1972-11-22 1976-09-07 Sterling Drug Inc. 1,2,3,4-Tetrahydrocarbazoles
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
US6645976B1 (en) * 1994-07-21 2003-11-11 Eli Lilly And Company Indolizine SPLA2inhibitors
DE69614232T2 (de) * 1995-12-13 2002-01-10 Eli Lilly And Co., Indianapolis Naphthyl-Acetamide als sPLA2-Inhibitoren
KR20000049210A (ko) * 1996-10-30 2000-07-25 피터 지. 스트링거 치환된 트리시클릭류
AU9664198A (en) * 1997-09-26 1999-04-23 Eli Lilly And Company Method for the treatment of cystic fibrosis
JP2001522884A (ja) * 1997-11-14 2001-11-20 イーライ・リリー・アンド・カンパニー アルツハイマー病の処置方法

Also Published As

Publication number Publication date
EP1156050B1 (en) 2004-02-18
SG106035A1 (en) 2004-09-30
EP1156050A3 (en) 2001-11-28
NO991823D0 (no) 1999-04-16
EP0950661B1 (en) 2003-11-12
HU9901219D0 (en) 1999-06-28
EP0950661A1 (en) 1999-10-20
ID23219A (id) 2000-03-30
DE69912670D1 (de) 2003-12-18
EA199900304A2 (ru) 1999-10-28
AU2381899A (en) 1999-10-28
JP4435325B2 (ja) 2010-03-17
ZA992773B (en) 2002-07-16
YU19099A (sh) 2001-09-28
CO5080728A1 (es) 2001-09-25
TW555760B (en) 2003-10-01
HUP9901219A1 (hu) 2000-08-28
AU757454B2 (en) 2003-02-20
CN1235968A (zh) 1999-11-24
BR9901275A (pt) 2000-05-02
ES2213668T3 (es) 2004-09-01
IL129484A0 (en) 2000-02-29
EP1156050A2 (en) 2001-11-21
NZ335252A (en) 2000-11-24
EA003129B1 (ru) 2003-02-27
EA199900304A3 (ru) 2000-04-24
ES2210979T3 (es) 2004-07-01
PE20000472A1 (es) 2000-06-02
DE69914951D1 (de) 2004-03-25
CA2269256A1 (en) 1999-10-17
AR018185A1 (es) 2001-10-31
PL332564A1 (en) 1999-10-25
ATE254128T1 (de) 2003-11-15
JPH11322745A (ja) 1999-11-24
DE69912670T2 (de) 2004-08-12
CZ137199A3 (cs) 1999-11-17
ATE259818T1 (de) 2004-03-15
SV1999000052A (es) 2000-03-14
DE69914951T2 (de) 2004-12-23
NO991823L (no) 1999-10-18
TR199900842A2 (xx) 2000-09-21

Similar Documents

Publication Publication Date Title
US6177440B1 (en) Substituted tricyclics
KR100586761B1 (ko) 치환된 트리시클릭류
US6384041B1 (en) Bicyclic sPLA2 inhibitors
ES2202560T3 (es) Triciclicos sustituidos.
EP1156050B1 (en) Substituted tricyclics useful in sPLA2 induced diseases
JP2001503055A5 (cg-RX-API-DMAC10.html)
US6608099B1 (en) Indole sPLA2 inhibitors
US6713645B1 (en) Substituted tricyclics
US6448284B1 (en) Substituted tricyclics
US6933313B2 (en) Substituted carbazoles as inhibitors of sPLA2
HK1025091A (en) Substituted tricyclics useful in spla2 induced diseases
MXPA99003588A (en) Triciclic composites substitui
MXPA99003587A (es) Compuestos triciclicos substituidos
HUP9903545A2 (hu) Helyettesített triciklusos vegyületek, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
HK1024912A (en) Substituted carbazoles, process for their preparation and their use as spla2 inhibitors

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19990416

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid